Sanofi’s business segments

Sanofi’s (SNY) business comprises three segments: Human Pharmaceuticals, Sanofi Pasteur (the Human Vaccines segment), and Others. The Human Pharmaceuticals portfolio includes specialized pharmaceutical products, generic pharmaceutical products, and consumer healthcare products.

In 2017, Sanofi exchanged Merial, its animal health business, with the consumer healthcare business of Boehringer Ingelheim.

Performance of Sanofi’s Business Segments in 4Q17

The chart above compares the segment-wise revenues for Sanofi since 1Q16. At constant exchange rates and with a constant structure, the company reported revenues of 8.7 billion euros, a decline of 1.6% in revenues in 4Q17.

Segment-wise performance in 4Q17

The Human Pharmaceuticals segment comprises pharmaceutical products and consumer healthcare products. This segment is further classified into several franchises—Sanofi Genzyme, the diabetes and cardiovascular franchise, general medicines and emerging markets, and the consumer healthcare franchise. The Pharmaceuticals segment reported revenues of 7.3 billion euros in 4Q17 for ~3.3% growth in revenues compared to 4Q16.

Sanofi Pasteur, the Human Vaccines segment, includes vaccines such as meningitis vaccines, pneumonia vaccines, adult booster vaccines, influenza vaccines, haemophilus influenza type b (or Hib) vaccines, polio vaccines, pertussis vaccines, and travel and other endemics vaccines. Sanofi Pasteur reported revenues of ~1.4 billion euros in 4Q17, for 8.7% growth in operating revenues compared to its 4Q16 revenues.

The PowerShares International Dividend Achievers ETF (PID) holds 10.1% of its total assets in healthcare companies. PID holds ~1.4% in Sanofi ADR (SNY), ~1.4% in Novartis ADR (NVS), ~1.0% in Novo Nordisk ADR (NVO), and ~4.8% in Teva Pharmaceuticals ADR (TEVA).

Latest articles

German chip maker Infineon Technologies has reportedly raised 1.55 billion euros (~$1.74 billion) in capital by selling its shares to fund its acquisition of Cypress Semiconductor (CY). Infineon has sold ~113 million new shares at 13.70 euros each.

As of June 18, Dunkin’ Brands (DNKN) was trading at $80.07, an 8.9% rise since reporting its first-quarter earnings on May 2. Also, DNKN was trading at a premium of 29.8% from its 52-week low of $61.69 and a discount of 1.6% from its 52-week high of $81.40.

19 Jun

Are Lower Oil Prices Weighing on ExxonMobil Stock?

WRITTEN BY Maitali Ramkumar

ExxonMobil (XOM) stock has fallen 7.1% in the second quarter so far. Let's review ExxonMobil's stock performance in comparison to oil price changes and equity market movements in the quarter.

19 Jun

As Facebook Unveils Libra, MSFT and CRM Join a Blockchain Group

WRITTEN BY Mayur Sontakke, CFA, FRM

On June 18, Facebook (FB) launched Libra, its own cryptocurrency. On the same day, CoinDesk published another piece of blockchain news that didn’t receive as much fanfare as Facebook’s Libra news. Was the timing a coincidence? We think not.

Uber Technologies (UBER) has picked Melbourne as another test site for its flying taxi service known as UberAir. The Australian city is the first international test site Uber has chosen for its flying taxi service. The addition of Melbourne brings the number of test locations Uber has picked for its UberAir service to three.

Lyft (LYFT) and Uber Technologies (UBER) are pushing back against California legislation that would require them to recognize their drivers as employees rather than independent contractors. The legislation would require companies like Lyft to give their drivers the compensation and benefits spelled out under California’s employment regulations.